Morphological, histopathological and immunohistochemical study of canine malignant lymphoma

Acta Veterinaria

Volumn 51, Issue 4, 2001, Pages 245-254

  Sanja, Aleksić Kovačević ^a   Jelesijevic T ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Dog; Immunohistochemistry; Lymphoma

Indexed keywords

EID: 0346406698     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aleksić-Kovačević S, 1999, Retrovirusne infekcije mačaka. Minax, Beograd.
2. Armstrong DE, Tomley FM, Nunes de Souza PA et al., 1982, Reverse transcriptase activity associated with canine leukaemia lymphosarcoma. In: Advances in Comparative Leukaemia Research. Yohn DS and Blakeslee JR (eds). Elsevier, New York, 411-412.
3. Bernard SM, 1988, Epidemiology of malignant lymphomas. In: Malignant lymphomas. Habeshaw JA and Lauder L (eds), Churchill Livingstone, London, 6-31.
4. Breuer W, Hermanns W, 1998, Classification of lymphohaemopietic neoplasias (LHN) in dogs and cats, Eur J Vet Pathol, 4, 5-20.
5. Chan JKC, Banks PM, Cleary M., Delsol G, De Wolf-Peeters C, Falini B et al., 1994, A proposal for classification of lymphoid neoplasms (by International Lymphoma Study Group). Histopath, 25, 517-36.
6. Greenlee PG, Filippa DA, Quimby FW et al., 1990, Lymphomas in dogs. A morphologic, immunologic and clinical study, Cancer, 66, 480-90.
7. Haga T, Yokomori K, Nakayama H et al., 1988, Canine and feline lymphoid and myeloid tumours encountered in Tokyo, Jpn J Vet Sci, 50, 809-13.
8. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML et al, 1994, A revised European-American classification of lymphoid neoplasm: A proposal from the International Lymphoma Study Group, Blood, 84, 1361-92.
9. Kipar A, Koehler K, Menger S, Reinacher M, 1998, Apoptosis in neoplastic cells of feline malignant lymphoma: potential role of FeLV, Fiffrs, Glasgow. p15E
10. nd Edition. Springer Verlag, Berlin.
11. Madewell BR, 1986, Haematological and bone marrow cytological abnormalities in 75 dogs with malignant lymphomas, JAAHA, 22, 235-40.
12. rd edition. University of California Press, Ltd. London, 231-307.
13. Onions DE, 1980, RNA dependent DNA polymerase activity in canine lymphosarcoma, Eur J Cancer, 16, 345-50.
14. Owen LN, Bostock DE, Halliwell REW, 1975, Cell-mediated and humoral immunity in dogs with spontaneous lymphosarcoma, Eur J Cancer, 11, 187-91.
15. Priester WA, McKay FW, 1980, The occurrence of tumours in domestic animals. Bethseda, Maryland, NCI Monogr., 54, 166.
16. Priester WA, 1967, Canine lymphoma: relative risk in the boxer breed. J Nat Canc Inst, 39, 833-44.
17. Reinacher M, Theilen GH, 1987, The frequency and significance of FeLV-infection in necropsied cats, Am J Vet Res, 48, 939-45.
18. Teste E, 1994, Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma, Vet Q, 16, 209-19.
19. Teste E, Vos JP, Egbemik HF et al., 1994a. Clustering in canine malignant lymphoma, Vet Q, 16, 134-6.
20. Teske E, Wisman P, Moore PF et al., 1994b, Histological classification and immunophenotyping of canine non-Hodgkin's lymphomas. Unexpected high frequency of T-cell lymphomas with B-cell morphology, Exp Hematol, 22, 1179-89.
21. Tomley FM, Armstrong SJ, Mahy BWJ et al., 1983, Reverse transcriptase activity and particles of retroviral density in cultured canine lymphosarcoma supernatants. Brit J Canc, 47, 277-84.
22. Vineis CB and the Working Group on the Epidemiology of Hematolymphopoietic Malignancies in Italy, 1996, Incidence and time trends for lymphomas, leukaemia's and myelomas: Hypothesis generation. Leuk Res, 20, 285-90.
23. Weiden P, Strob R, Kolb HJ et al., 1974, Immune reactivity in dogs with spontaneous malignancy. J Nat Cane Inst, 53, 1049-56.